Egalet
Wayne, US · Delaware corporation · 2 known investors
Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products. It operates in the pharmaceutical industry focused on pain treatment.
BiotechHealthtechMedical Devices
Founders & leadership
BA
BARBARA A. CARLINSENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER
RS
ROBERT S. RADIECHIEF EXECUTIVE OFFICER
MS
MARK STROBECKEXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER
MT
MEGAN TIMMINSSENIOR VICE PRESIDENT AND GENERAL COUNSEL
PM
PATRICK M. SHEASENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER
JM
Jeffrey M. DaynoChief Medical Officer
KL
Karsten LindhardtSenior Vice President
DM
Deanne MelloyChief Commercial Officer
SM
Stan MusialChief Financial Officer
AH
ANDREA HESLIN SMILEYNamed on SEC filing
JM
JOSEPH MCINNISNamed on SEC filing
MP
MATTHEW PAULSNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$42.2M disclosed across 1 round · 2019
▶$42.2MraisedFeb 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$42.2MraisedFeb 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ANDREA HESLIN SMILEYDirector
- JOSEPH MCINNISDirector
- BARBARA A. CARLINExecutive Officer
- MATTHEW PAULSDirector
- TODD HOLMESDirector
- ROBERT S. RADIEExecutive Officer, Director
- TIMOTHY P. WALBERTDirector
- MARK STROBECKExecutive Officer
- MEGAN TIMMINSExecutive Officer
- LUKE DUSTERDirector
- PATRICK M. SHEAExecutive Officer
- Offering amount
- $42.2M
- Amount sold
- $42.2M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Egalet for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Egalet do?
- Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products. It operates in the pharmaceutical industry focused on pain treatment.
- Who are Egalet's investors?
- Egalet's investors include Sunstone Capital, Atlas Venture.
- How much funding has Egalet raised?
- Egalet has disclosed $42.2M raised across 1 round.
- Where is Egalet headquartered?
- Egalet is headquartered in Wayne, US.